Evidence map›Paper›PMID 26961959›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2016

Age-Related Changes in D-Aspartate Oxidase Promoter Methylation Control Extracellular D-Aspartate Levels and Prevent Precocious Cell Death during Brain Aging.

Daniela Punzo, Francesco Errico, Luigia Cristino, Silvia Sacchi, Simona Keller, Carmela Belardo, Livio Luongo, Tommaso Nuzzo, Roberta Imperatore, Ermanno Florio and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Article
  3. Crystal structure of D-aspartate oxidase from Cryptococcus humicola UJ1.Acta crystallographica. Section F, Structural biology communications · 2025
    Article
  4. Article
  5. Aspartate in the Brain: A Review.Neurochemical research · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. On the regulation of human D-aspartate oxidase.Protein science : a publication of the Protein Society · 2023
    Article
  14. Article
  15. Biomarkers of Activity-Dependent Plasticity and Persistent Enhancement of Synaptic Transmission in Alzheimer Disease: A Review of the Current Status.Medical science monitor : international medical journal of experimental and clinical research · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 1 country.

Daniela PunzoIstituto di Endocrinologia ed Oncologia Sperimentale, Consiglio Nazionale delle Ricerche (CNR), 80131 Naples, Italy, Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, Second University of Naples, 81100 Caserta, Italy.
Francesco ErricoLaboratory of Behavioural Neuroscience, Ceinge Biotecnologie Avanzate, 80145 Naples, Italy, Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy.ORCID http://orcid.org/0000-0002-3636-7395
Luigia CristinoInstitute of Biomolecular Chemistry, CNR, 80078 Pozzuoli, Italy.
Silvia SacchiDepartment of Biotechnology and Life Sciences, University of Insubria, 21100 Varese, Italy, Protein Factory Research Center, Politecnico di Milano and University of Insubria, 20133 Milan, Italy.ORCID http://orcid.org/0000-0002-2338-2561
Simona KellerIstituto di Endocrinologia ed Oncologia Sperimentale, Consiglio Nazionale delle Ricerche (CNR), 80131 Naples, Italy, Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy.
Carmela BelardoDepartment of Experimental Medicine, Section of Pharmacology, Second University of Naples, 80138 Naples, Italy.
Livio LuongoDepartment of Experimental Medicine, Section of Pharmacology, Second University of Naples, 80138 Naples, Italy.
Tommaso NuzzoDepartment of Environmental, Biological and Pharmaceutical Sciences and Technologies, Second University of Naples, 81100 Caserta, Italy, Laboratory of Behavioural Neuroscience, Ceinge Biotecnologie Avanzate, 80145 Naples, Italy.ORCID http://orcid.org/0000-0002-2397-3417
Roberta ImperatoreInstitute of Biomolecular Chemistry, CNR, 80078 Pozzuoli, Italy.
Ermanno FlorioIstituto di Endocrinologia ed Oncologia Sperimentale, Consiglio Nazionale delle Ricerche (CNR), 80131 Naples, Italy, Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy.
Vito De NovellisDepartment of Experimental Medicine, Section of Pharmacology, Second University of Naples, 80138 Naples, Italy.
Ornella AffinitoIstituto di Endocrinologia ed Oncologia Sperimentale, Consiglio Nazionale delle Ricerche (CNR), 80131 Naples, Italy, Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy.ORCID http://orcid.org/0000-0002-8355-9509
Sara MigliariniDepartment of Biology, Unit of Cell and Developmental Biology, University of Pisa, 56126 Pisa, Italy, and.ORCID http://orcid.org/0000-0003-2741-269X
Giacomo MaddaloniDepartment of Biology, Unit of Cell and Developmental Biology, University of Pisa, 56126 Pisa, Italy, and.ORCID http://orcid.org/0000-0002-0485-8544
Maria Josè SisalliIstituto di Endocrinologia ed Oncologia Sperimentale, Consiglio Nazionale delle Ricerche (CNR), 80131 Naples, Italy.
Massimo PasqualettiDepartment of Biology, Unit of Cell and Developmental Biology, University of Pisa, 56126 Pisa, Italy, and Center for Neuroscience and Cognitive Systems, Istituto Italiano di Tecnologia, 38068 Rovereto, Italy.ORCID http://orcid.org/0000-0002-0844-8139
Loredano PollegioniDepartment of Biotechnology and Life Sciences, University of Insubria, 21100 Varese, Italy, Protein Factory Research Center, Politecnico di Milano and University of Insubria, 20133 Milan, Italy.ORCID http://orcid.org/0000-0003-1733-7243
Sabatino MaioneDepartment of Experimental Medicine, Section of Pharmacology, Second University of Naples, 80138 Naples, Italy.
Lorenzo ChiariottiIstituto di Endocrinologia ed Oncologia Sperimentale, Consiglio Nazionale delle Ricerche (CNR), 80131 Naples, Italy, Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy, chiariot@unina.it usiello@ceinge.unina.it.
Alessandro UsielloDepartment of Environmental, Biological and Pharmaceutical Sciences and Technologies, Second University of Naples, 81100 Caserta, Italy, Laboratory of Behavioural Neuroscience, Ceinge Biotecnologie Avanzate, 80145 Naples, Italy, chiariot@unina.it usiello@ceinge.unina.it.
University of Campania "Luigi Vanvitelli" · ITInstitute for Experimental Endocrinology and Oncology · ITUniversity of Pisa · ITUniversity of Insubria · ITCeinge Biotecnologie Avanzate (Italy) · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The endogenous NMDA receptor (NMDAR) agonist D-aspartate occurs transiently in the mammalian brain because it is abundant during embryonic and perinatal phases before drastically decreasing during adulthood. It is well established that postnatal reduction of cerebral D-aspartate levels is due to the concomitant onset of D-aspartate oxidase (DDO) activity, a flavoenzyme that selectively degrades bicarboxylic D-amino acids. In the present work, we show that d-aspartate content in the mouse brain drastically decreases after birth, whereas Ddo mRNA levels concomitantly increase. Interestingly, postnatal Ddo gene expression is paralleled by progressive demethylation within its putative promoter region. Consistent with an epigenetic control on Ddo expression, treatment with the DNA-demethylating agent, azacitidine, causes increased mRNA levels in embryonic cortical neurons. To indirectly evaluate the effect of a putative persistent Ddo gene hypermethylation in the brain, we used Ddo knock-out mice (Ddo(-/-)), which show constitutively suppressed Ddo expression. In these mice, we found for the first time substantially increased extracellular content of d-aspartate in the brain. In line with detrimental effects produced by NMDAR overstimulation, persistent elevation of D-aspartate levels in Ddo(-/-) brains is associated with appearance of dystrophic microglia, precocious caspase-3 activation, and cell death in cortical pyramidal neurons and dopaminergic neurons of the substantia nigra pars compacta. This evidence, along with the early accumulation of lipufuscin granules in Ddo(-/-) brains, highlights an unexpected importance of Ddo demethylation in preventing neurodegenerative processes produced by nonphysiological extracellular levels of free D-aspartate.

Indexed as

AgingAge FactorsAnimalsAnimals, NewbornAzacitidineBrainCell DeathD-Aspartate OxidaseD-Aspartic AcidDecitabineEmbryo, MammalianEnzyme InhibitorsMaleMethylationMiceMice, Inbred C57BLAzacitidineD-Aspartate OxidaseD-Aspartic AcidDecitabineEnzyme InhibitorsReceptors, N-Methyl-D-AspartateRNA, Messengeragingd-amino acidsDNA methylationneurodegenerationNMDA receptor

Identifiers

PMID26961959
PMCPMC6601755
OpenAlexW2296643995

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.